Publication details

The redox environment triggers conformational changes and aggregation of hIAPP in Type II Diabetes

Authors

CAMARGO D.C.R. TRIPSIANES Konstantinos BUDAY K. FRANKO A. GOBL C. HARTLMULLER C. SARKAR R. AICHLER M. METTENLEITER G. SCHULZ M. BODDRICH A. ERCK C. MARTENS H. WALCH A.K. MADL T. WANKER E.E. CONRAD M. DE ANGELIS M.H. REIF B.

Year of publication 2017
Type Article in Periodical
Magazine / Source Scientific reports
MU Faculty or unit

Central European Institute of Technology

Citation
web https://www.nature.com/articles/srep44041.pdf
Doi http://dx.doi.org/10.1038/srep44041
Keywords ISLET AMYLOID POLYPEPTIDE; ENDOPLASMIC-RETICULUM STRESS; DISULFIDE-BOND FORMATION; PANCREATIC BETA-CELLS; HUMAN AMYLIN; HUMAN-IAPP; INSULIN; PROTEINS; NMR; GLUTATHIONE
Description Type II diabetes (T2D) is characterized by diminished insulin production and resistance of cells to insulin. Among others, endoplasmic reticulum (ER) stress is a principal factor contributing to T2D and induces a shift towards a more reducing cellular environment. At the same time, peripheral insulin resistance triggers the over-production of regulatory hormones such as insulin and human islet amyloid polypeptide (hIAPP). We show that the differential aggregation of reduced and oxidized hIAPP assists to maintain the redox equilibrium by restoring redox equivalents. Aggregation thus induces redox balancing which can assist initially to counteract ER stress. Failure of the protein degradation machinery might finally result in beta-cell disruption and cell death. We further present a structural characterization of hIAPP in solution, demonstrating that the N-terminus of the oxidized peptide has a high propensity to form an alpha-helical structure which is lacking in the reduced state of hIAPP. In healthy cells, this residual structure prevents the conversion into amyloidogenic aggregates.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info